60 acast.com eHIV Review https://podcast.dkbmed.com/category/ehiv/ en DKBmed 2019 eHIV Review eHIV Review podcast channel

Hosted on Acast. See acast.com/privacy for more information.

]]>

Hosted on Acast. See acast.com/privacy for more information.

]]> false eHIV Review info+5fa6e0fa73fc5b37cc75ce31@mg-eu.acast.com 5fa6e0fa73fc5b37cc75ce31 ehivreview https://podcast.dkbmed.com/feed/ehiv/ episodic https://assets.pippa.io/shows/5fa6e0fa73fc5b37cc75ce31/1606931191774-6b783d2614b0ac4c30a7ad038d3a106f.jpeg https://podcast.dkbmed.com/category/ehiv/ eHIV Review https://feeds.acast.com/public/shows/5fa6e0fa73fc5b37cc75ce31 PrEP: The Newest Chapter PrEP: The Newest Chapter Fri, 27 Feb 2026 04:27:34 GMT 20:06 69a11d36e4e1627e8ce0c497 false https://shows.acast.com/ehivreview/episodes/prep-the-newest-chapter 69a11d36e4e1627e8ce0c497 5fa6e0fa73fc5b37cc75ce31 prep-the-newest-chapter full 10 8 In this issue: The long-awaited approval of a second long-acting injectable PrEP formulation — twice-yearly lenacapavir — has come. What are the most important things clinicians need to understand when considering prescribing this new agent?  

How does Q6 months LA lenacapavir differ from already available LA cabotegravir? Which patients is appropriate for? What kinds of monitoring are required, both at treatment initiation and with every following injection? What are the predominant safety issues, and how should they be managed?   

Join us as Matthew Spinelli, MD, MAS, Associate Professor of HIV, Infectious Disease, and Global Medicine at Zuckerberg San Francisco General Hospital, shares his experience and expertise in helping clinicians considering either of these LA PrEP options … in this issue of eHIV Review. 

Hosted on Acast. See acast.com/privacy for more information.

]]> In this issue: The long-awaited approval of a second long-acting injectable PrEP formulation — twice-yearly lenacapavir — has come. What are the most important things clinicians need to understand when considering prescribing this new agent?  

How does Q6 months LA lenacapavir differ from already available LA cabotegravir? Which patients is appropriate for? What kinds of monitoring are required, both at treatment initiation and with every following injection? What are the predominant safety issues, and how should they be managed?   

Join us as Matthew Spinelli, MD, MAS, Associate Professor of HIV, Infectious Disease, and Global Medicine at Zuckerberg San Francisco General Hospital, shares his experience and expertise in helping clinicians considering either of these LA PrEP options … in this issue of eHIV Review. 

Hosted on Acast. See acast.com/privacy for more information.

]]> <![CDATA[Youth & HIV: Understanding the Unique Challenges]]> Wed, 03 Dec 2025 15:44:14 GMT 24:46 69305ace042629ee0e8e70b4 false https://elit.dkbmed.com/issues/232 69305ace042629ee0e8e70b4 5fa6e0fa73fc5b37cc75ce31 youth-hiv-understanding-the-unique-challenges full 10 6 In this issue we focus on youth: the 13 to 24-year-old population responsible for nearly 20% of new HIV diagnoses in the US. Their entry into the HIV care continuum has been slow, hindered by barriers that are just now beginning to be recognized and overcome. What’s been done, what’s being done, and what needs to be done to better educate and motivate this critically important under-diagnosed and under-treated community? 

Join Dr. David C. Griffith from the Departments of Medicine and Pediatrics at the Johns Hopkins University School of Medicine in Baltimore, as he shares his knowledge and expertise in identifying and managing youth at risk for becoming infected, as well as those already living with, HIV — in this issue of eHIV Review. 

Hosted on Acast. See acast.com/privacy for more information.

]]> In this issue we focus on youth: the 13 to 24-year-old population responsible for nearly 20% of new HIV diagnoses in the US. Their entry into the HIV care continuum has been slow, hindered by barriers that are just now beginning to be recognized and overcome. What’s been done, what’s being done, and what needs to be done to better educate and motivate this critically important under-diagnosed and under-treated community? 

Join Dr. David C. Griffith from the Departments of Medicine and Pediatrics at the Johns Hopkins University School of Medicine in Baltimore, as he shares his knowledge and expertise in identifying and managing youth at risk for becoming infected, as well as those already living with, HIV — in this issue of eHIV Review. 

Hosted on Acast. See acast.com/privacy for more information.

]]> Managing HIV-Related Comorbidities in an Aging Population Managing HIV-Related Comorbidities in an Aging Population Tue, 30 Sep 2025 18:51:56 GMT 24:17 68dc26cc46a2532cdd6d386e false https://elit.dkbmed.com/issues/230 68dc26cc46a2532cdd6d386e 5fa6e0fa73fc5b37cc75ce31 managing-hiv-related-comorbidities-in-an-aging-population full 10 4 PWH. People living with HIV. They’re growing older. And they’re experiencing the same illnesses of aging — CVD, kidney and liver diseases, cancers — as their HIV-seronegative counterparts.  

The question is: how should they be treated?  

Should the comorbidities of aging PWH be managed with the same agents and dosing regimens as people the same age who have not been fighting a chronic infective condition? How do the treatments that have increased PWH wellness and expected lifespans affect the safety and efficacy of the preferred comorbidity management options? What does the evidence-based data say? 

Join Dr. Maile Young Karris, Co-Director of the San Diego Center for AIDS Research Clinical Investigations Core, and an Associate Professor from the Department of Medicine at the University of California in San Diego, as we discuss strategies to mitigate the effects of comorbidities in older people living with HIV — in this issue of eHIV Review. 

Hosted on Acast. See acast.com/privacy for more information.

]]> PWH. People living with HIV. They’re growing older. And they’re experiencing the same illnesses of aging — CVD, kidney and liver diseases, cancers — as their HIV-seronegative counterparts.  

The question is: how should they be treated?  

Should the comorbidities of aging PWH be managed with the same agents and dosing regimens as people the same age who have not been fighting a chronic infective condition? How do the treatments that have increased PWH wellness and expected lifespans affect the safety and efficacy of the preferred comorbidity management options? What does the evidence-based data say? 

Join Dr. Maile Young Karris, Co-Director of the San Diego Center for AIDS Research Clinical Investigations Core, and an Associate Professor from the Department of Medicine at the University of California in San Diego, as we discuss strategies to mitigate the effects of comorbidities in older people living with HIV — in this issue of eHIV Review. 

Hosted on Acast. See acast.com/privacy for more information.

]]> Overcoming Barriers to PrEP in Rural America Overcoming Barriers to PrEP in Rural America Thu, 14 Aug 2025 10:00:00 GMT 30:51 6888f75b69e88bb085fd79ea false https://elit.dkbmed.com/issues/228 6888f75b69e88bb085fd79ea 5fa6e0fa73fc5b37cc75ce31 overcoming-barriers-to-prep-in-rural-america full 9 2 PrEP. For most patients, that’s a simple drug regimen that can be prescribed after a negative HIV screen. Safe. Effective. Proactive protection to stop the spread of HIV infection in MSM, cisgender, and transgender individuals.


Post-test for CME credits: https://elit.dkbmed.com/issues/228/test

Hosted on Acast. See acast.com/privacy for more information.

]]> PrEP. For most patients, that’s a simple drug regimen that can be prescribed after a negative HIV screen. Safe. Effective. Proactive protection to stop the spread of HIV infection in MSM, cisgender, and transgender individuals.


Post-test for CME credits: https://elit.dkbmed.com/issues/228/test

Hosted on Acast. See acast.com/privacy for more information.

]]> New Directions in Long-Acting ART and Long-Acting PrEP New Directions in Long-Acting ART and Long-Acting PrEP Fri, 28 Mar 2025 10:00:00 GMT 40:40 67d9a2298e0ad1dccd8c25eb false https://elit.dkbmed.com/issues/226 67d9a2298e0ad1dccd8c25eb 5fa6e0fa73fc5b37cc75ce31 new-directions-in-long-acting-art-and-long-acting-prep full 9 12 How will the current research advancements in long-acting ART affect clinicians’ ability to provide better care for their patients with HIV? The recent data show that the low uptake and adherence to PrEP may be largely due to the pill burden and potential stigma of daily dosing. How might the newer longer-acting PrEP regimens challenge this reluctance?


Post-test for CME credits: https://elit.dkbmed.com/issues/226/test

Hosted on Acast. See acast.com/privacy for more information.

]]> How will the current research advancements in long-acting ART affect clinicians’ ability to provide better care for their patients with HIV? The recent data show that the low uptake and adherence to PrEP may be largely due to the pill burden and potential stigma of daily dosing. How might the newer longer-acting PrEP regimens challenge this reluctance?


Post-test for CME credits: https://elit.dkbmed.com/issues/226/test

Hosted on Acast. See acast.com/privacy for more information.

]]> <![CDATA[PLWH & SUD: A Clinical Perspective]]> Tue, 10 Dec 2024 08:00:52 GMT 31:26 6745eb93b505b826d70d9ee2 false https://elit.dkbmed.com/issues/217 6745eb93b505b826d70d9ee2 5fa6e0fa73fc5b37cc75ce31 plwh-sud-a-clinical-perspective full 9 10 The primary health concern for all individuals living with HIV should be managing their disease, particularly maintaining adherence to their ART treatment. Yet for many, the more immediate demands of their substance use disorder — whether for stimulants and/or opioids — take precedence and can readily become the central focus of their lives. What signals can help a clinician recognize a substance use disorder? How can they differentiate a clinical SUD from intermittent (even though harmful) substance use? What evidence-based treatments should they consider?


Post-test for CME credits: https://elit.dkbmed.com/issues/217/test

Hosted on Acast. See acast.com/privacy for more information.

]]> The primary health concern for all individuals living with HIV should be managing their disease, particularly maintaining adherence to their ART treatment. Yet for many, the more immediate demands of their substance use disorder — whether for stimulants and/or opioids — take precedence and can readily become the central focus of their lives. What signals can help a clinician recognize a substance use disorder? How can they differentiate a clinical SUD from intermittent (even though harmful) substance use? What evidence-based treatments should they consider?


Post-test for CME credits: https://elit.dkbmed.com/issues/217/test

Hosted on Acast. See acast.com/privacy for more information.

]]> PLWH: Overcoming Post-Incarceration Care Disengagement PLWH: Overcoming Post-Incarceration Care Disengagement Tue, 22 Oct 2024 14:00:08 GMT 20:17 67089cbf14b366c897df41b8 false https://elit.dkbmed.com/issues/213 67089cbf14b366c897df41b8 5fa6e0fa73fc5b37cc75ce31 plwh-overcoming-post-incarceration-care-disengagement full 9 8 People living with HIV who’ve had criminal legal involvement face significant challenges that complicate their ability to remain in the HIV care continuum. Many, while incarcerated, have stopped treatment, and once back in the community have been reluctant to resume ART. Why? What are the key drivers behind their disengagement from care? What can clinicians do to encourage these patients to return to treatment? What strategies have been tried, and what’s been shown to work? What does the evidence say?


Post-test for CME credits: https://elit.dkbmed.com/issues/213/test

Hosted on Acast. See acast.com/privacy for more information.

]]> People living with HIV who’ve had criminal legal involvement face significant challenges that complicate their ability to remain in the HIV care continuum. Many, while incarcerated, have stopped treatment, and once back in the community have been reluctant to resume ART. Why? What are the key drivers behind their disengagement from care? What can clinicians do to encourage these patients to return to treatment? What strategies have been tried, and what’s been shown to work? What does the evidence say?


Post-test for CME credits: https://elit.dkbmed.com/issues/213/test

Hosted on Acast. See acast.com/privacy for more information.

]]> Managing HIV in an Aging Population Managing HIV in an Aging Population Fri, 23 Aug 2024 14:00:20 GMT 28:21 66b7c5b46b3febd2709af8d0 false https://elit.dkbmed.com/issues/206 66b7c5b46b3febd2709af8d0 5fa6e0fa73fc5b37cc75ce31 managing-hiv-in-an-aging-population full 9 6 Widespread use of highly effective ART has increased the life expectancy of people living with HIV (PLWH) to close to that of the general population. But despite highly effective viral suppression, the risks for cardiovascular diseases continue to increase in these individuals. So too do the risks of neurocognitive impairment.


Post-test for CME credits: https://elit.dkbmed.com/issues/206/test

Hosted on Acast. See acast.com/privacy for more information.

]]> Widespread use of highly effective ART has increased the life expectancy of people living with HIV (PLWH) to close to that of the general population. But despite highly effective viral suppression, the risks for cardiovascular diseases continue to increase in these individuals. So too do the risks of neurocognitive impairment.


Post-test for CME credits: https://elit.dkbmed.com/issues/206/test

Hosted on Acast. See acast.com/privacy for more information.

]]> Managing HIV Coinfections: HBV and TB Managing HIV Coinfections: HBV and TB Thu, 20 Jun 2024 11:00:31 GMT 33:45 6661c3db3664c200115baa55 false https://elit.dkbmed.com/issues/203 6661c3db3664c200115baa55 5fa6e0fa73fc5b37cc75ce31 managing-hiv-coinfections-hbv-and-tb full 9 4 Current ART regimens can successfully manage HIV infection in nearly all PLWH. But what happens when a patient with HIV is coinfected with a dangerous pathogen ART alone cannot handle? Two of the most common are hepatitis B and latent tuberculosis infection.


Post-test for CME credits: https://elit.dkbmed.com/issues/203/test

Hosted on Acast. See acast.com/privacy for more information.

]]> Current ART regimens can successfully manage HIV infection in nearly all PLWH. But what happens when a patient with HIV is coinfected with a dangerous pathogen ART alone cannot handle? Two of the most common are hepatitis B and latent tuberculosis infection.


Post-test for CME credits: https://elit.dkbmed.com/issues/203/test

Hosted on Acast. See acast.com/privacy for more information.

]]> ART, HRT, Pregnancy, and Menopause in Women Living With HIV ART, HRT, Pregnancy, and Menopause in Women Living With HIV Thu, 06 Jun 2024 14:10:07 GMT 24:45 661ee12e7d6300001668b508 false https://elit.dkbmed.com/issues/201 661ee12e7d6300001668b508 5fa6e0fa73fc5b37cc75ce31 art-hrt-pregnancy-and-menopause-in-women-living-with-hiv full 9 2 Pregnancy and menopause — for many women, these are two of the most significant healthcare events in their lives. For WLWH (women living with HIV) and their healthcare providers, managing these life-changing periods is often complicated by many questions.


Post-test for CME credits: https://elit.dkbmed.com/issues/201

Hosted on Acast. See acast.com/privacy for more information.

]]> Pregnancy and menopause — for many women, these are two of the most significant healthcare events in their lives. For WLWH (women living with HIV) and their healthcare providers, managing these life-changing periods is often complicated by many questions.


Post-test for CME credits: https://elit.dkbmed.com/issues/201

Hosted on Acast. See acast.com/privacy for more information.

]]> Clinical Approaches to Marginalized Populations Clinical Approaches to Marginalized Populations Wed, 24 Jan 2024 12:00:57 GMT 35:03 659eff8c7b4c4b0016d0ad29 false https://elit.dkbmed.com/issues/191 659eff8c7b4c4b0016d0ad29 5fa6e0fa73fc5b37cc75ce31 addressing-the-needs-of-marginalized-populations full In part 1 of this eHIV Review Special Edition (still available at eHIVreview.org), eHIV Review Program Director Justin Alves, Nurse Educator at Boston Medical Center, reviewed the recent evidence describing some of the barriers to care experienced by marginalized individuals at risk for or living with HIV. In this Part 2 issue, he again calls upon two front-line clinicians in the fight to end the HIV epidemic in the U.S. — Nicky Mehtani, MD, from UCSF Medical Center in San Francisco, and Vanessa Loukas, NP, from Boston University’s Chobanian & Avedisian School of Medicine —to share their clinical approaches.


Post test for CME/CE credit: https://elit.dkbmed.com/issues/191/test

Hosted on Acast. See acast.com/privacy for more information.

]]> In part 1 of this eHIV Review Special Edition (still available at eHIVreview.org), eHIV Review Program Director Justin Alves, Nurse Educator at Boston Medical Center, reviewed the recent evidence describing some of the barriers to care experienced by marginalized individuals at risk for or living with HIV. In this Part 2 issue, he again calls upon two front-line clinicians in the fight to end the HIV epidemic in the U.S. — Nicky Mehtani, MD, from UCSF Medical Center in San Francisco, and Vanessa Loukas, NP, from Boston University’s Chobanian & Avedisian School of Medicine —to share their clinical approaches.


Post test for CME/CE credit: https://elit.dkbmed.com/issues/191/test

Hosted on Acast. See acast.com/privacy for more information.

]]> Addressing the Needs of Marginalized Populations - Mehtani Addressing the Needs of Marginalized Populations - Mehtani Wed, 24 Jan 2024 12:00:56 GMT 4:43 659ec0c2d18deb0016cb3d1d false https://elit.dkbmed.com/issues/190 659ec0c2d18deb0016cb3d1d 5fa6e0fa73fc5b37cc75ce31 addressing-the-needs-of-marginalized-populations-mehtani full

Hosted on Acast. See acast.com/privacy for more information.

]]>

Hosted on Acast. See acast.com/privacy for more information.

]]> Addressing the Needs of Marginalized Populations - Loukas Addressing the Needs of Marginalized Populations - Loukas Wed, 24 Jan 2024 12:00:32 GMT 2:18 659ec10f0ce3940017af497f false https://elit.dkbmed.com/issues/190 659ec10f0ce3940017af497f 5fa6e0fa73fc5b37cc75ce31 addressing-the-needs-of-marginalized-populations-loukas full

Hosted on Acast. See acast.com/privacy for more information.

]]>

Hosted on Acast. See acast.com/privacy for more information.

]]> HIV Stigma: A Psychologist’s Viewpoint HIV Stigma: A Psychologist’s Viewpoint Fri, 22 Dec 2023 12:00:17 GMT 30:59 6581cc3c306e8300167acd63 false https://elit.dkbmed.com/issues/183 6581cc3c306e8300167acd63 5fa6e0fa73fc5b37cc75ce31 hiv-stigma-a-psychologists-viewpoint full 8 12 A wealth of evidence confirms that adolescents and young adults (AYA) are indeed a priority population whose needs must be addressed for the US Ending the HIV Epidemic program to be successful. What do providers need to know about AYA to bring more of these patients into the HIV care continuum? What should they be doing? And what should they avoid doing?


Join us as guest author Dr. Vincent Guilamo-Ramos from the Duke University School of Nursing answers these and other questions, in this issue of eHIV Review.


Post test for CME/CE credit: https://elit.dkbmed.com/issues/183/test


Companion newsletter: https://elit.dkbmed.com/issues/182

Hosted on Acast. See acast.com/privacy for more information.

]]> A wealth of evidence confirms that adolescents and young adults (AYA) are indeed a priority population whose needs must be addressed for the US Ending the HIV Epidemic program to be successful. What do providers need to know about AYA to bring more of these patients into the HIV care continuum? What should they be doing? And what should they avoid doing?


Join us as guest author Dr. Vincent Guilamo-Ramos from the Duke University School of Nursing answers these and other questions, in this issue of eHIV Review.


Post test for CME/CE credit: https://elit.dkbmed.com/issues/183/test


Companion newsletter: https://elit.dkbmed.com/issues/182

Hosted on Acast. See acast.com/privacy for more information.

]]> AYA and Ending the HIV Epidemic AYA and Ending the HIV Epidemic Thu, 07 Dec 2023 17:17:59 GMT 25:29 654161a088ac54001275e72a false https://shows.acast.com/ehivreview/episodes/aya-and-ending-the-hiv-epidemic 654161a088ac54001275e72a 5fa6e0fa73fc5b37cc75ce31 aya-and-ending-the-hiv-epidemic full 8 10 A wealth of evidence confirms that adolescents and young adults (AYA) are indeed a priority population whose needs must be addressed for the US Ending the HIV Epidemic program to be successful. What do providers need to know about AYA to bring more of these patients into the HIV care continuum? What should they be doing? And what should they avoid doing?


Join us as guest author Dr. Vincent Guilamo-Ramos from the Duke University School of Nursing answers these and other questions, in this issue of eHIV Review.


Post test for CME/CE credit: https://elit.dkbmed.com/issues/179/test


Companion newsletter: https://elit.dkbmed.com/issues/175

Hosted on Acast. See acast.com/privacy for more information.

]]> A wealth of evidence confirms that adolescents and young adults (AYA) are indeed a priority population whose needs must be addressed for the US Ending the HIV Epidemic program to be successful. What do providers need to know about AYA to bring more of these patients into the HIV care continuum? What should they be doing? And what should they avoid doing?


Join us as guest author Dr. Vincent Guilamo-Ramos from the Duke University School of Nursing answers these and other questions, in this issue of eHIV Review.


Post test for CME/CE credit: https://elit.dkbmed.com/issues/179/test


Companion newsletter: https://elit.dkbmed.com/issues/175

Hosted on Acast. See acast.com/privacy for more information.

]]> Delivering High-Quality HIV Care to Cisgender and Transgender Women Delivering High-Quality HIV Care to Cisgender and Transgender Women Thu, 03 Aug 2023 13:52:21 GMT 26:14 64bfd8698577ee0011f4bb7f false https://shows.acast.com/ehivreview/episodes/delivering-high-quality-hiv-care-to-cisgender-and-transgende 64bfd8698577ee0011f4bb7f 5fa6e0fa73fc5b37cc75ce31 delivering-high-quality-hiv-care-to-cisgender-and-transgende full 8 8 Why do cisgender and transgender women, and particularly women of color, account for such a disproportionate percentage of HIV infections in the US? Why are so many so reluctant to accept PrEP? What can clinicians do to bridge this critical gap in essential HIV services?

These are some of the questions Guest Author Dr. Kathleen McManus, from the Division of Infectious Diseases and International Health at the University of Virginia, discusses in this issue of eHIV Review.


Take our post-test to claim CME credits.

Read this podcast's companion newsletter here.

Hosted on Acast. See acast.com/privacy for more information.

]]> Why do cisgender and transgender women, and particularly women of color, account for such a disproportionate percentage of HIV infections in the US? Why are so many so reluctant to accept PrEP? What can clinicians do to bridge this critical gap in essential HIV services?

These are some of the questions Guest Author Dr. Kathleen McManus, from the Division of Infectious Diseases and International Health at the University of Virginia, discusses in this issue of eHIV Review.


Take our post-test to claim CME credits.

Read this podcast's companion newsletter here.

Hosted on Acast. See acast.com/privacy for more information.

]]> Newer NNRTI Agents in Clinical Practice Newer NNRTI Agents in Clinical Practice Tue, 11 Jul 2023 20:11:06 GMT 27:40 64628e5f576ce90011e30171 false https://shows.acast.com/ehivreview/episodes/newer-nnrti-agents-in-clinical-practice 64628e5f576ce90011e30171 5fa6e0fa73fc5b37cc75ce31 newer-nnrti-agents-in-clinical-practice full 8 6 Non-nucleoside reverse transcriptase inhibitors (NNRTIs). Rilpivirine, in combination with cabotegravir, provides a long-acting injectable option for both treatment and PrEP. But what risk factors have been associated with virologic failure? Doravirine appears to provide a favorable impact on weight and lipid outcomes, but with a lower genetic barrier to resistance. Which patients is it right for and in which ones should it be avoided?

Join us as we discuss Newer NNRTI Agents in Clinical Practice with Dr. Darcy Wooten from the Division of Infectious Disease at the University of California, San Diego, in this issue of eHIV Review.


Take our post-test to claim CME credits.

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

]]> Non-nucleoside reverse transcriptase inhibitors (NNRTIs). Rilpivirine, in combination with cabotegravir, provides a long-acting injectable option for both treatment and PrEP. But what risk factors have been associated with virologic failure? Doravirine appears to provide a favorable impact on weight and lipid outcomes, but with a lower genetic barrier to resistance. Which patients is it right for and in which ones should it be avoided?

Join us as we discuss Newer NNRTI Agents in Clinical Practice with Dr. Darcy Wooten from the Division of Infectious Disease at the University of California, San Diego, in this issue of eHIV Review.


Take our post-test to claim CME credits.

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

]]> Emerging HIV Therapies and Potential Clinical Uses Emerging HIV Therapies and Potential Clinical Uses Sun, 30 Apr 2023 12:21:16 GMT 25:37 643ffd2ca189ca0011e41235 false https://shows.acast.com/ehivreview/episodes/emerging-hiv-therapies-and-potential-clinical-uses 643ffd2ca189ca0011e41235 5fa6e0fa73fc5b37cc75ce31 emerging-hiv-therapies-and-potential-clinical-uses full 8 4

Hosted on Acast. See acast.com/privacy for more information.

]]>

Hosted on Acast. See acast.com/privacy for more information.

]]> Stigma and HIV Care in LGBTQ+ Persons Stigma and HIV Care in LGBTQ+ Persons Thu, 12 Jan 2023 15:17:40 GMT 20:30 63b6ef378d926b00113a60b1 false https://shows.acast.com/ehivreview/episodes/stigma-and-hiv-care-in-lgbtq-persons 63b6ef378d926b00113a60b1 5fa6e0fa73fc5b37cc75ce31 stigma-and-hiv-care-in-lgbtq-persons full 8 2 Stigma. What is it, and where does it come from? How do LGBTQ+ individuals, particularly those with HIV, experience it? How does stigma affect their mental health? What effect does it have on their engagement in HIV care? What do health care providers need to change to minimize stigma in their practices? 


These are some of the questions advanced practice nurse Dallas Ducar, CEO of Transhealth, discusses in this issue of eHIV Review. 


Take our post-test to claim CME credits.

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

]]> Stigma. What is it, and where does it come from? How do LGBTQ+ individuals, particularly those with HIV, experience it? How does stigma affect their mental health? What effect does it have on their engagement in HIV care? What do health care providers need to change to minimize stigma in their practices? 


These are some of the questions advanced practice nurse Dallas Ducar, CEO of Transhealth, discusses in this issue of eHIV Review. 


Take our post-test to claim CME credits.

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

]]> Newer Options for Treatment-Experienced Patients Podcast Newer Options for Treatment-Experienced Patients Podcast Tue, 11 Oct 2022 15:38:59 GMT 33:52 6335c5e1a204e2001414046e false https://shows.acast.com/ehivreview/episodes/newer-options-for-treatment-experienced-patients-podcast 6335c5e1a204e2001414046e 5fa6e0fa73fc5b37cc75ce31 newer-options-for-treatment-experienced-patients-podcast full 7 12 Treatment-experienced patients with RAMs — resistance-associated mutations — remain a difficult management challenge. Every case of HIV drug resistance requires a therapeutic regimen individualized for each patient’s ART history. How will new and in-development agents affect the equation?

Which drug combinations are right? Where does the balance between side effects and adherence lie?

These are some of the questions Dr. Brian Wood from the Division of Allergy and Infectious Diseases at the University of Washington in Seattle addresses in this eHIV Review podcast.


Take our post-test to claim CME credits.

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

]]> Treatment-experienced patients with RAMs — resistance-associated mutations — remain a difficult management challenge. Every case of HIV drug resistance requires a therapeutic regimen individualized for each patient’s ART history. How will new and in-development agents affect the equation?

Which drug combinations are right? Where does the balance between side effects and adherence lie?

These are some of the questions Dr. Brian Wood from the Division of Allergy and Infectious Diseases at the University of Washington in Seattle addresses in this eHIV Review podcast.


Take our post-test to claim CME credits.

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

]]> Weight Gain in PLWH: A Clinical Concern Weight Gain in PLWH: A Clinical Concern Wed, 07 Sep 2022 17:03:11 GMT 27:22 630e3278b373f60012b18379 false https://shows.acast.com/ehivreview/episodes/weight-gain-in-plwh-a-clinical-concern 630e3278b373f60012b18379 5fa6e0fa73fc5b37cc75ce31 weight-gain-in-plwh-a-clinical-concern full 7 10 Most people living with HIV gain weight when initiating ART. For some, the weight gain signifies a “return to health”; for others, the additional weight can be clinically significant and may be strongly associated with an increased risk of metabolic abnormalities. What causes this weight gain? How can patients most at risk for weight-related comorbidities be identified? 

Join us as we discuss these and other issues with Dr. Todd Brown, Professor of Medicine and Epidemiology at Johns Hopkins University, in this eHIV Review podcast. 


Take our post-test to claim CME credits.

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

]]> Most people living with HIV gain weight when initiating ART. For some, the weight gain signifies a “return to health”; for others, the additional weight can be clinically significant and may be strongly associated with an increased risk of metabolic abnormalities. What causes this weight gain? How can patients most at risk for weight-related comorbidities be identified? 

Join us as we discuss these and other issues with Dr. Todd Brown, Professor of Medicine and Epidemiology at Johns Hopkins University, in this eHIV Review podcast. 


Take our post-test to claim CME credits.

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

]]> COVID-19: The Morbidity/Mortality Risk COVID-19: The Morbidity/Mortality Risk Thu, 26 May 2022 14:47:00 GMT 22:51 6272af465798790017da3bf1 false https://shows.acast.com/ehivreview/episodes/covid-19-the-morbiditymortality-risk 6272af465798790017da3bf1 5fa6e0fa73fc5b37cc75ce31 covid-19-the-morbiditymortality-risk full 7 8 Are PLWH at higher risk for increased mortality from COVID-19 infection? How important is it for PWLH to get vaccinated and boosted? Is breakthrough COVID-19 infection more likely to occur among PLWH? What about “long COVID” (PASC)?

Join Clinical Research Nurse Diane Kanjilal, manager of the Infectious Disease Clinical Research Unit at Massachusetts General Hospital, as we discuss these questions in this eHIV Review podcast.


Take our post-test to claim CME credits.

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

]]> Are PLWH at higher risk for increased mortality from COVID-19 infection? How important is it for PWLH to get vaccinated and boosted? Is breakthrough COVID-19 infection more likely to occur among PLWH? What about “long COVID” (PASC)?

Join Clinical Research Nurse Diane Kanjilal, manager of the Infectious Disease Clinical Research Unit at Massachusetts General Hospital, as we discuss these questions in this eHIV Review podcast.


Take our post-test to claim CME credits.

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

]]> Clinical Uses of LA Injectable ART Clinical Uses of LA Injectable ART Thu, 07 Apr 2022 19:50:11 GMT 25:51 624f40ccfb31910014b5d60e false https://shows.acast.com/ehivreview/episodes/clinical-uses-of-la-injectable-art 624f40ccfb31910014b5d60e 5fa6e0fa73fc5b37cc75ce31 clinical-uses-of-la-injectable-art full 7 6 Long-acting injectable antiretroviral therapy is expected to improve adherence, reduce patient burden, and lower community viral load. But for which patients is it suitable? Can it be used as pre-exposure prophylaxis? How does the promise of long-acting ART actually mean in practice?</p><p>Join us for this <em>e</em>HIV Review podcast, as Dr. Tanyaporn Wansom, Senior Infectious Diseases Consultant at Chayun Consulting in Bangkok Thailand, takes us to the clinic to answer some of these key questions


Take our post-test to claim CME credits.

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

]]> Long-acting injectable antiretroviral therapy is expected to improve adherence, reduce patient burden, and lower community viral load. But for which patients is it suitable? Can it be used as pre-exposure prophylaxis? How does the promise of long-acting ART actually mean in practice?</p><p>Join us for this <em>e</em>HIV Review podcast, as Dr. Tanyaporn Wansom, Senior Infectious Diseases Consultant at Chayun Consulting in Bangkok Thailand, takes us to the clinic to answer some of these key questions


Take our post-test to claim CME credits.

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

]]> <![CDATA[Adolescents & Young Adults: Engaging the Vulnerable 20%]]> Tue, 22 Mar 2022 14:54:02 GMT 19:21 6089788ed2c56f6ca9f9dcb1 false https://shows.acast.com/ehivreview/episodes/engaging-the-vulnerable-20 6089788ed2c56f6ca9f9dcb1 5fa6e0fa73fc5b37cc75ce31 engaging-the-vulnerable-20 full 7 4 Twenty percent of new HIV diagnoses occur among adolescents and young adults. They’re a population underserved by HIV prevention resources, with lower retention in HIV care. Their awareness and uptake of PrEP has been and remains low. What can their clinicians do to more effectively help these vulnerable young people?  

Join Dr. Luis Rubio from University of California San Francisco as we explore these and other important issues in this eHIV Review podcast. 


Take our post-test to claim CME credits.

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

]]> Twenty percent of new HIV diagnoses occur among adolescents and young adults. They’re a population underserved by HIV prevention resources, with lower retention in HIV care. Their awareness and uptake of PrEP has been and remains low. What can their clinicians do to more effectively help these vulnerable young people?  

Join Dr. Luis Rubio from University of California San Francisco as we explore these and other important issues in this eHIV Review podcast. 


Take our post-test to claim CME credits.

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

]]> Rapid ART: Benefits and Clinical Considerations Rapid ART: Benefits and Clinical Considerations Tue, 08 Mar 2022 15:20:35 GMT 24:17 622773e11b00e2001448f776 false https://shows.acast.com/ehivreview/episodes/rapid-art-benefits-and-clinical-considerations 622773e11b00e2001448f776 5fa6e0fa73fc5b37cc75ce31 rapid-art-benefits-and-clinical-considerations full 7 2 Rapid ART — initiating ART as soon as possible after an HIV diagnosis: How effective is it at bringing people with newly diagnosed HIV into lasting care? When and how should it be initiated? Are there particular populations where attempting rapid ART should be avoided?  

Join us as we discuss these issues with Dr. Jonathan Colasanti from Atlanta’s Emory University and Grady Health System, in this eHIV Review podcast. 


Take our post-test to claim CME credits.

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

]]> Rapid ART — initiating ART as soon as possible after an HIV diagnosis: How effective is it at bringing people with newly diagnosed HIV into lasting care? When and how should it be initiated? Are there particular populations where attempting rapid ART should be avoided?  

Join us as we discuss these issues with Dr. Jonathan Colasanti from Atlanta’s Emory University and Grady Health System, in this eHIV Review podcast. 


Take our post-test to claim CME credits.

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

]]> Engaging Undocumented Latinx People In HIV Care Engaging Undocumented Latinx People In HIV Care Tue, 08 Mar 2022 15:17:23 GMT 23:04 622772eab8290c0016939a48 false https://shows.acast.com/ehivreview/episodes/engaging-undocumented-latinx-people-in-hiv-care 622772eab8290c0016939a48 5fa6e0fa73fc5b37cc75ce31 engaging-undocumented-latinx-people-in-hiv-care full 6 12 Undocumented LatinX immigrants are a special population facing many difficulties that hinder their engagement in HIV care and prevention. One obvious barrier is language: many undocumented immigrants do not understand either spoken or written English. Many may have never received routine medical care before and can be baffled by the complexities of the medical system. Insurance status and financial concerns are additional barriers. Finally, HIV-related stigma and fear of disclosure of their HIV and/or immigration status can prevent undocumented Latinx immigrants from engaging in HIV care and prevention.  

How can clinicians most effectively help these individuals receive proper care? Join us as we find out, with Dr. Kathleen Page and nurse Owen Smith from Johns Hopkins University, in this eHIV Review podcast. 


Take our post-test to claim CME credits.

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

]]> Undocumented LatinX immigrants are a special population facing many difficulties that hinder their engagement in HIV care and prevention. One obvious barrier is language: many undocumented immigrants do not understand either spoken or written English. Many may have never received routine medical care before and can be baffled by the complexities of the medical system. Insurance status and financial concerns are additional barriers. Finally, HIV-related stigma and fear of disclosure of their HIV and/or immigration status can prevent undocumented Latinx immigrants from engaging in HIV care and prevention.  

How can clinicians most effectively help these individuals receive proper care? Join us as we find out, with Dr. Kathleen Page and nurse Owen Smith from Johns Hopkins University, in this eHIV Review podcast. 


Take our post-test to claim CME credits.

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.

]]> Critical Factors When Switching ART Critical Factors When Switching ART Wed, 21 Jul 2021 16:47:17 GMT 18:12 60f84f0ec565b20012ff87cf false https://elit.dkbmed.com/issues/112 60f84f0ec565b20012ff87cf 5fa6e0fa73fc5b37cc75ce31 critical-factors-when-switching-art full 6 10 Better tolerability. More convenient dosing. Less serious side effects. Fewer potential drug-drug interactions. These are some of the most common reasons why individuals living with HIV want or need to change their currently successful ART regimens. 


But what do clinicians need to consider when determining which ART to switch to? What role do the patient’s comorbidities play in the selection process? How do changes in the patient’s condition not related to HIV affect the safety and efficacy of their current regimen? What does the evidence say? 


Join us in this eHIV Review podcast for a case-based discussion with Dr. Natasha Chida, from the Division of Infectious Diseases at the Johns Hopkins University School of Medicine, about these increasingly important issues. 


Claim CME/CEU credit: Critical Factors When Switching ART | DKBmed

Hosted on Acast. See acast.com/privacy for more information.

]]> Better tolerability. More convenient dosing. Less serious side effects. Fewer potential drug-drug interactions. These are some of the most common reasons why individuals living with HIV want or need to change their currently successful ART regimens. 


But what do clinicians need to consider when determining which ART to switch to? What role do the patient’s comorbidities play in the selection process? How do changes in the patient’s condition not related to HIV affect the safety and efficacy of their current regimen? What does the evidence say? 


Join us in this eHIV Review podcast for a case-based discussion with Dr. Natasha Chida, from the Division of Infectious Diseases at the Johns Hopkins University School of Medicine, about these increasingly important issues. 


Claim CME/CEU credit: Critical Factors When Switching ART | DKBmed

Hosted on Acast. See acast.com/privacy for more information.

]]> Weight Gain and Hormone Therapy Weight Gain and Hormone Therapy Thu, 27 May 2021 11:29:33 GMT 18:42 6093efe97cc77f3316918c99 false https://elit.dkbmed.com/issues/110 6093efe97cc77f3316918c99 5fa6e0fa73fc5b37cc75ce31 weight-gain-and-hormone-therapy full 6 8 Do antivirals increase weight gain? Does PrEP reduce the effect of gender-affirming hormone therapy in transgender women? 

Join us in the clinic with Dr. Sarah Puryear from the University of California San Francisco as we discuss these important questions. 


Take our post-test to claim CME credits.

Hosted on Acast. See acast.com/privacy for more information.

]]> Do antivirals increase weight gain? Does PrEP reduce the effect of gender-affirming hormone therapy in transgender women? 

Join us in the clinic with Dr. Sarah Puryear from the University of California San Francisco as we discuss these important questions. 


Take our post-test to claim CME credits.

Hosted on Acast. See acast.com/privacy for more information.

]]> Identifying HIV Infection in the ED Identifying HIV Infection in the ED Thu, 06 May 2021 14:01:18 GMT 21:29 605a13ca1c9869028f17cdc2 false https://shows.acast.com/ehivreview/episodes/identifying-hiv-infection-in-the-ed 605a13ca1c9869028f17cdc2 5fa6e0fa73fc5b37cc75ce31 identifying-hiv-infection-in-the-ed full 6 6

Hosted on Acast. See acast.com/privacy for more information.

]]>

Hosted on Acast. See acast.com/privacy for more information.

]]> Screening Strategies to Prevent HIV in MSM and Transgender Women Screening Strategies to Prevent HIV in MSM and Transgender Women Thu, 28 Jan 2021 16:08:19 GMT 14:59 600f2d3b94295616f6e92727 false https://elit.dkbmed.com/issues/99 600f2d3b94295616f6e92727 5fa6e0fa73fc5b37cc75ce31 screening-strategies-to-prevent-hiv-in-msm-and-transgender-w full 6 4 Nearly two of three new HIV infections in the United States appear in transgender women and men who have sex with men (MSM), with most transmission coming from people unaware of their infection. What should clinicians do to increase the rate of HIV screening in these populations to meet guideline recommendations? 


In this eHIV Review podcast, Dr. Robert Goldstein from Harvard Medical School and Massachusetts General Hospital takes us to the clinic to explain how HIV risk in these special populations can be identified and infection prevented. 


Take our post-test to claim CME credits.

Hosted on Acast. See acast.com/privacy for more information.

]]> Nearly two of three new HIV infections in the United States appear in transgender women and men who have sex with men (MSM), with most transmission coming from people unaware of their infection. What should clinicians do to increase the rate of HIV screening in these populations to meet guideline recommendations? 


In this eHIV Review podcast, Dr. Robert Goldstein from Harvard Medical School and Massachusetts General Hospital takes us to the clinic to explain how HIV risk in these special populations can be identified and infection prevented. 


Take our post-test to claim CME credits.

Hosted on Acast. See acast.com/privacy for more information.

]]> HIV and COVID-19: The Data and The Real World HIV and COVID-19: The Data and The Real World Thu, 17 Dec 2020 20:56:21 GMT 38:33 5fdbc5f5731459568c828625 false https://shows.acast.com/ehivreview/episodes/hiv-and-covid-19-the-data-and-the-real-world 5fdbc5f5731459568c828625 5fa6e0fa73fc5b37cc75ce31 hiv-and-covid-19-the-data-and-the-real-world The impact of COVID-19 on the care of patients with or at risk of HIV. full What do the currently published findings say about the effects of the COVID pandemic on people living with HIV? How is the pandemic affecting patients and clinicians in HIV care delivery and the health of people living with HIV?


That’s the dual focus of this eHIV Review Special Edition issue. Matthew Spinelli, MD, MAS, assistant professor in the Division of HIV, ID, and Global Medicine at the University of California, San Francisco and San Francisco General Hospital, analyzes the current literature that addresses these questions, and then speaks directly with front-line clinicians about what they’re experiencing as they navigate a disrupted health care system. 


In addition to presenting his analysis of the data-driven evidence describing the effects of the COVID-19 virus on people with living with HIV, Dr. Spinelli also spoke directly with front-line clinicians to learn about what they’ve been experiencing as they work to maintain their patients’ health in this disrupted health care system.


Take our post-test to claim CME credits.

Hosted on Acast. See acast.com/privacy for more information.

]]> What do the currently published findings say about the effects of the COVID pandemic on people living with HIV? How is the pandemic affecting patients and clinicians in HIV care delivery and the health of people living with HIV?


That’s the dual focus of this eHIV Review Special Edition issue. Matthew Spinelli, MD, MAS, assistant professor in the Division of HIV, ID, and Global Medicine at the University of California, San Francisco and San Francisco General Hospital, analyzes the current literature that addresses these questions, and then speaks directly with front-line clinicians about what they’re experiencing as they navigate a disrupted health care system. 


In addition to presenting his analysis of the data-driven evidence describing the effects of the COVID-19 virus on people with living with HIV, Dr. Spinelli also spoke directly with front-line clinicians to learn about what they’ve been experiencing as they work to maintain their patients’ health in this disrupted health care system.


Take our post-test to claim CME credits.

Hosted on Acast. See acast.com/privacy for more information.

]]> Immune Response in People with HIV Immune Response in People with HIV Tue, 01 Dec 2020 11:00:58 GMT 6:43 5fc7bf2177c40a7813e4a30c false https://shows.acast.com/ehivreview/episodes/immune-response-in-people-with-hiv 5fc7bf2177c40a7813e4a30c 5fa6e0fa73fc5b37cc75ce31 immune-response-in-people-with-hiv full What do the currently published findings say about the effects of the COVID pandemic on people living with HIV? How is the pandemic affecting patients and clinicians in HIV care delivery and the health of people living with HIV?


That’s the dual focus of this eHIV Review Special Edition issue. Matthew Spinelli, MD, MAS, assistant professor in the Division of HIV, ID, and Global Medicine at the University of California, San Francisco and San Francisco General Hospital, analyzes the current literature that addresses these questions, and then speaks directly with front-line clinicians about what they’re experiencing as they navigate a disrupted health care system. 

Hosted on Acast. See acast.com/privacy for more information.

]]> What do the currently published findings say about the effects of the COVID pandemic on people living with HIV? How is the pandemic affecting patients and clinicians in HIV care delivery and the health of people living with HIV?


That’s the dual focus of this eHIV Review Special Edition issue. Matthew Spinelli, MD, MAS, assistant professor in the Division of HIV, ID, and Global Medicine at the University of California, San Francisco and San Francisco General Hospital, analyzes the current literature that addresses these questions, and then speaks directly with front-line clinicians about what they’re experiencing as they navigate a disrupted health care system. 

Hosted on Acast. See acast.com/privacy for more information.

]]> Challenges Supporting PLWH Challenges Supporting PLWH Tue, 01 Dec 2020 11:00:51 GMT 6:49 5fc7be6215575e0df9c80873 false https://shows.acast.com/ehivreview/episodes/challenges-supporting-plwh 5fc7be6215575e0df9c80873 5fa6e0fa73fc5b37cc75ce31 challenges-supporting-plwh HIV and COVID with Elizabeth Lynch, MSN, RN full What do the currently published findings say about the effects of the COVID pandemic on people living with HIV? How is the pandemic affecting patients and clinicians in HIV care delivery and the health of people living with HIV?


That’s the dual focus of this eHIV Review Special Edition issue. Matthew Spinelli, MD, MAS, assistant professor in the Division of HIV, ID, and Global Medicine at the University of California, San Francisco and San Francisco General Hospital, analyzes the current literature that addresses these questions, and then speaks directly with front-line clinicians about what they’re experiencing as they navigate a disrupted health care system. 

Hosted on Acast. See acast.com/privacy for more information.

]]> What do the currently published findings say about the effects of the COVID pandemic on people living with HIV? How is the pandemic affecting patients and clinicians in HIV care delivery and the health of people living with HIV?


That’s the dual focus of this eHIV Review Special Edition issue. Matthew Spinelli, MD, MAS, assistant professor in the Division of HIV, ID, and Global Medicine at the University of California, San Francisco and San Francisco General Hospital, analyzes the current literature that addresses these questions, and then speaks directly with front-line clinicians about what they’re experiencing as they navigate a disrupted health care system. 

Hosted on Acast. See acast.com/privacy for more information.

]]> Impact on HIV Treatment and Prevention Services Impact on HIV Treatment and Prevention Services Tue, 01 Dec 2020 11:00:46 GMT 5:04 5fc7bd0305b2bf12b0da2a55 false https://shows.acast.com/ehivreview/episodes/impact-on-hiv-treatment-and-prevention-services 5fc7bd0305b2bf12b0da2a55 5fa6e0fa73fc5b37cc75ce31 impact-on-hiv-treatment-and-prevention-services HIV and COVID-19 with Jessica Bloome, MD, MPH full What do the currently published findings say about the effects of the COVID pandemic on people living with HIV? How is the pandemic affecting patients and clinicians in HIV care delivery and the health of people living with HIV?


That’s the dual focus of this eHIV Review Special Edition issue. Matthew Spinelli, MD, MAS, assistant professor in the Division of HIV, ID, and Global Medicine at the University of California, San Francisco and San Francisco General Hospital, analyzes the current literature that addresses these questions, and then speaks directly with front-line clinicians about what they’re experiencing as they navigate a disrupted health care system. 

Hosted on Acast. See acast.com/privacy for more information.

]]> What do the currently published findings say about the effects of the COVID pandemic on people living with HIV? How is the pandemic affecting patients and clinicians in HIV care delivery and the health of people living with HIV?


That’s the dual focus of this eHIV Review Special Edition issue. Matthew Spinelli, MD, MAS, assistant professor in the Division of HIV, ID, and Global Medicine at the University of California, San Francisco and San Francisco General Hospital, analyzes the current literature that addresses these questions, and then speaks directly with front-line clinicians about what they’re experiencing as they navigate a disrupted health care system. 

Hosted on Acast. See acast.com/privacy for more information.

]]> Case Study: HIV and COVID-19 Interaction Case Study: HIV and COVID-19 Interaction Tue, 01 Dec 2020 11:00:44 GMT 5:39 5fc7bfa977c40a7813e4a30f false https://shows.acast.com/ehivreview/episodes/case-study-hiv-and-covid-19-interaction 5fc7bfa977c40a7813e4a30f 5fa6e0fa73fc5b37cc75ce31 case-study-hiv-and-covid-19-interaction HIV and COVID with Chloe Lynne Thio, MD full What do the currently published findings say about the effects of the COVID pandemic on people living with HIV? How is the pandemic affecting patients and clinicians in HIV care delivery and the health of people living with HIV?


That’s the dual focus of this eHIV Review Special Edition issue. Matthew Spinelli, MD, MAS, assistant professor in the Division of HIV, ID, and Global Medicine at the University of California, San Francisco and San Francisco General Hospital, analyzes the current literature that addresses these questions, and then speaks directly with front-line clinicians about what they’re experiencing as they navigate a disrupted health care system. 

Hosted on Acast. See acast.com/privacy for more information.

]]> What do the currently published findings say about the effects of the COVID pandemic on people living with HIV? How is the pandemic affecting patients and clinicians in HIV care delivery and the health of people living with HIV?


That’s the dual focus of this eHIV Review Special Edition issue. Matthew Spinelli, MD, MAS, assistant professor in the Division of HIV, ID, and Global Medicine at the University of California, San Francisco and San Francisco General Hospital, analyzes the current literature that addresses these questions, and then speaks directly with front-line clinicians about what they’re experiencing as they navigate a disrupted health care system. 

Hosted on Acast. See acast.com/privacy for more information.

]]> Clinical Presentations Among PLWH Clinical Presentations Among PLWH Tue, 01 Dec 2020 11:00:19 GMT 5:27 5fc7bc67e82b112b414a72c9 false https://elit.dkbmed.com/issues/93 5fc7bc67e82b112b414a72c9 5fa6e0fa73fc5b37cc75ce31 clinical-presentations-among-plwh HIV and COVID with Annie Antar, MD, PhD full What do the currently published findings say about the effects of the COVID pandemic on people living with HIV? How is the pandemic affecting patients and clinicians in HIV care delivery and the health of people living with HIV?


That’s the dual focus of this eHIV Review Special Edition issue. Matthew Spinelli, MD, MAS, assistant professor in the Division of HIV, ID, and Global Medicine at the University of California, San Francisco and San Francisco General Hospital, analyzes the current literature that addresses these questions, and then speaks directly with front-line clinicians about what they’re experiencing as they navigate a disrupted health care system. 

Hosted on Acast. See acast.com/privacy for more information.

]]> What do the currently published findings say about the effects of the COVID pandemic on people living with HIV? How is the pandemic affecting patients and clinicians in HIV care delivery and the health of people living with HIV?


That’s the dual focus of this eHIV Review Special Edition issue. Matthew Spinelli, MD, MAS, assistant professor in the Division of HIV, ID, and Global Medicine at the University of California, San Francisco and San Francisco General Hospital, analyzes the current literature that addresses these questions, and then speaks directly with front-line clinicians about what they’re experiencing as they navigate a disrupted health care system. 

Hosted on Acast. See acast.com/privacy for more information.

]]> Harm Reduction Strategies for People Who Inject Drugs Harm Reduction Strategies for People Who Inject Drugs Fri, 20 Nov 2020 02:07:00 GMT 19:25 5fabf051de9cbd14f2df7760 false https://elit.dkbmed.com/issues/90 5fabf051de9cbd14f2df7760 5fa6e0fa73fc5b37cc75ce31 harm-reduction-strategies-for-people-who-inject-drugs Barriers to HIV screening in people who inject drugs and the impact of improved access to harm reduction services. full 6 2 Take our post-test to claim CME credits.


To read a companion newsletter click here.


Why do PWID — people who inject drugs — continue as an uncontrolled source of HIV infection? Where are the missed opportunities for increased screening in this population? What barriers have been identified and what strategies can successfully overcome them? Which harm reduction initiatives have been proved effective, and can they be cost-effectively replicated? 


In this eHIV Review podcast, Dr. Josh Barocas from the Boston University School of Medicine and Boston Medical Center, and Dr. Raagini Jawa, an infectious disease and addiction medicine fellow at Boston Medical Center, provide a clinical perspective on these important questions. 

Hosted on Acast. See acast.com/privacy for more information.

]]> Take our post-test to claim CME credits.


To read a companion newsletter click here.


Why do PWID — people who inject drugs — continue as an uncontrolled source of HIV infection? Where are the missed opportunities for increased screening in this population? What barriers have been identified and what strategies can successfully overcome them? Which harm reduction initiatives have been proved effective, and can they be cost-effectively replicated? 


In this eHIV Review podcast, Dr. Josh Barocas from the Boston University School of Medicine and Boston Medical Center, and Dr. Raagini Jawa, an infectious disease and addiction medicine fellow at Boston Medical Center, provide a clinical perspective on these important questions. 

Hosted on Acast. See acast.com/privacy for more information.

]]> <![CDATA[PrEP, STIs, & Sexual Health Conversations]]> Wed, 09 Sep 2020 22:17:24 GMT 21:24 https://podcast.dkbmed.com/?p=937 false https://shows.acast.com/ehivreview/episodes/prep-stis-sexual-health-conversations 5fa6e10573fc5b37cc75ce33 5fa6e0fa73fc5b37cc75ce31 prep-stis-sexual-health-conversations STI prevention strategies that should be offered to MSM as part of routine sexual health care. full 5 12 Take our post-test to claim CME credits.

To read a companion newsletter click here.

Both the on-going syphilis and HIV epidemics are highly concentrated among men who have sex with men. While PrEP has been proven to reduce HIV transmission, it is not designed to prevent sexually transmitted infections like gonorrhea, syphilis, and chlamydia. What does the evidence say about reducing STI risk in MSM, and how can it be most effectively applied in practice? 

In this podcast, Dr. Matthew Spinelli — Assistant Professor in the Division of HIV, ID, and Global Medicine at the University of California, San Francisco and San Francisco General Hospital — takes us to the clinic to explain what providers can do to help their patients avoid acquiring and transmitting STIs.

Hosted on Acast. See acast.com/privacy for more information.

]]> Take our post-test to claim CME credits.

To read a companion newsletter click here.

Both the on-going syphilis and HIV epidemics are highly concentrated among men who have sex with men. While PrEP has been proven to reduce HIV transmission, it is not designed to prevent sexually transmitted infections like gonorrhea, syphilis, and chlamydia. What does the evidence say about reducing STI risk in MSM, and how can it be most effectively applied in practice? 

In this podcast, Dr. Matthew Spinelli — Assistant Professor in the Division of HIV, ID, and Global Medicine at the University of California, San Francisco and San Francisco General Hospital — takes us to the clinic to explain what providers can do to help their patients avoid acquiring and transmitting STIs.

Hosted on Acast. See acast.com/privacy for more information.

]]> Clinical Insights: Expanding HIV Testing and Treatment Clinical Insights: Expanding HIV Testing and Treatment Wed, 08 Jul 2020 20:18:05 GMT 13:51 https://podcast.dkbmed.com/?p=860 false https://shows.acast.com/ehivreview/episodes/5fa6e10573fc5b37cc75ce34 5fa6e10573fc5b37cc75ce34 5fa6e0fa73fc5b37cc75ce31 Different HIV testing options and the potential benefits and limitations of HIV self-testing strategies. full 5 10 Take our post-test to claim CME credits.

To read a companion newsletter click here.

Our ability to reduce HIV infection and transmission depends on testing, in particular assessing the status of at-risk people who continue to remain untested.  

In this issue, Dr. Cedric Bien-Gund from the Division of Infectious Diseases at the University of Pennsylvania takes us to the clinic to explain the pros and cons of the currently available HIV tests and explains which are best to use in particular clinical circumstances.

Hosted on Acast. See acast.com/privacy for more information.

]]> Take our post-test to claim CME credits.

To read a companion newsletter click here.

Our ability to reduce HIV infection and transmission depends on testing, in particular assessing the status of at-risk people who continue to remain untested.  

In this issue, Dr. Cedric Bien-Gund from the Division of Infectious Diseases at the University of Pennsylvania takes us to the clinic to explain the pros and cons of the currently available HIV tests and explains which are best to use in particular clinical circumstances.

Hosted on Acast. See acast.com/privacy for more information.

]]> In the Clinic: HIV and Aging In the Clinic: HIV and Aging Fri, 08 May 2020 15:56:49 GMT 17:18 https://podcast.dkbmed.com/?p=797 false https://shows.acast.com/ehivreview/episodes/5fa6e10573fc5b37cc75ce35 5fa6e10573fc5b37cc75ce35 5fa6e0fa73fc5b37cc75ce31 full 5 8 Take our post-test to claim CME credits.

To read a companion newsletter click here.

In the US, nearly half of all people living with HIV are now aged 50 years or older. Their health care providers face new challenges in managing the effects of aging in their patients. In this eHIV Review podcast, Dr. Maile Young Karris from the University of California San Diego provides clinical insight into HIV and aging.

Hosted on Acast. See acast.com/privacy for more information.

]]> Take our post-test to claim CME credits.

To read a companion newsletter click here.

In the US, nearly half of all people living with HIV are now aged 50 years or older. Their health care providers face new challenges in managing the effects of aging in their patients. In this eHIV Review podcast, Dr. Maile Young Karris from the University of California San Diego provides clinical insight into HIV and aging.

Hosted on Acast. See acast.com/privacy for more information.

]]> Increasing PrEP Uptake in Women Increasing PrEP Uptake in Women Fri, 03 Apr 2020 05:00:00 GMT 17:23 https://podcast.dkbmed.com/?p=750 false https://shows.acast.com/ehivreview/episodes/5fa6e10573fc5b37cc75ce36 5fa6e10573fc5b37cc75ce36 5fa6e0fa73fc5b37cc75ce31 The importance of HIV prevention and pre-exposure prophylaxis in women. full 5 6 Take our post-test to claim CME credits.

To read a companion newsletter click here.

In the US, among women at high risk for acquiring HIV infection, only around 2% have initiated PrEP.  What are the patient, provider, and system barriers to increased PrEP uptake in this vulnerable population?  What can clinicians do to overcome these barriers? 


In this issue, Dr. Rachel Scott, Scientific Director of Women's Health Research at the MedStar Health Research Institute and Assistant Professor of Obstetrics and Gynecology at the Georgetown University School of Medicine, provides some answers.

Hosted on Acast. See acast.com/privacy for more information.

]]> Take our post-test to claim CME credits.

To read a companion newsletter click here.

In the US, among women at high risk for acquiring HIV infection, only around 2% have initiated PrEP.  What are the patient, provider, and system barriers to increased PrEP uptake in this vulnerable population?  What can clinicians do to overcome these barriers? 


In this issue, Dr. Rachel Scott, Scientific Director of Women's Health Research at the MedStar Health Research Institute and Assistant Professor of Obstetrics and Gynecology at the Georgetown University School of Medicine, provides some answers.

Hosted on Acast. See acast.com/privacy for more information.

]]> Increasing PrEP Uptake in PWID Increasing PrEP Uptake in PWID Mon, 09 Mar 2020 18:26:33 GMT 25:17 https://podcast.dkbmed.com/?p=728 false https://shows.acast.com/ehivreview/episodes/5fa6e10573fc5b37cc75ce37 5fa6e10573fc5b37cc75ce37 5fa6e0fa73fc5b37cc75ce31 The barriers to PrEP uptake among PWID, and both provider-level and systems-level strategies that may improve PrEP access. full 5 4 Take our post-test to claim CME credits.

To read a companion newsletter click here.

People who inject drugs (PWID) are at risk for HIV infection from both sexual- as well as injection-related causes. What can clinicians do to reduce the incidence of infection and improve their patients’ health?


In this issue, Dr. Jessica Taylor from The Boston University School of Medicine and Boston Medical Center takes us into the clinic to explain how current evidence-based strategies can increase the uptake of HIV pre-exposure prophylaxis in this vulnerable population.

Hosted on Acast. See acast.com/privacy for more information.

]]> Take our post-test to claim CME credits.

To read a companion newsletter click here.

People who inject drugs (PWID) are at risk for HIV infection from both sexual- as well as injection-related causes. What can clinicians do to reduce the incidence of infection and improve their patients’ health?


In this issue, Dr. Jessica Taylor from The Boston University School of Medicine and Boston Medical Center takes us into the clinic to explain how current evidence-based strategies can increase the uptake of HIV pre-exposure prophylaxis in this vulnerable population.

Hosted on Acast. See acast.com/privacy for more information.

]]> Two Drug ART? — Clinical Considerations Two Drug ART? — Clinical Considerations Mon, 23 Dec 2019 17:12:00 GMT 26:32 https://podcast.dkbmed.com/?p=710 false https://shows.acast.com/ehivreview/episodes/5fa6e10573fc5b37cc75ce38 5fa6e10573fc5b37cc75ce38 5fa6e0fa73fc5b37cc75ce31 Appropriate and inappropriate patients and circumstances for a two-drug regimen as initial therapy. full 5 2 Take our post-test to claim CME credits.



To read a companion newsletter click here.


In her recent newsletter issue (eHIV Review V5 #1), Dr. Ethel Weld, Assistant Professor of Medicine, Pharmacology and Molecular Sciences at the Johns Hopkins School of Medicine, analyzed the current research about the potential uses of two-drug ART regimens. Join her now for a case-based discussion about how that new information can affect patient selection in the clinic.

Hosted on Acast. See acast.com/privacy for more information.

]]> Take our post-test to claim CME credits.



To read a companion newsletter click here.


In her recent newsletter issue (eHIV Review V5 #1), Dr. Ethel Weld, Assistant Professor of Medicine, Pharmacology and Molecular Sciences at the Johns Hopkins School of Medicine, analyzed the current research about the potential uses of two-drug ART regimens. Join her now for a case-based discussion about how that new information can affect patient selection in the clinic.

Hosted on Acast. See acast.com/privacy for more information.

]]> “U=U” — Clinical Considerations “U=U” — Clinical Considerations Thu, 25 Jul 2019 06:00:02 GMT 23:51 https://podcast.dkbmed.com/?p=680 false https://shows.acast.com/ehivreview/episodes/5fa6e10573fc5b37cc75ce39 5fa6e10573fc5b37cc75ce39 5fa6e0fa73fc5b37cc75ce31 Volume 4, Issue 12 “U=U” — an Undetectable HIV viral load means Untransmittable HIV virus.  In her recent eHIV Newsletter Issue (Vol. 4; No. 11), Dr. Jill Blumenthal from the Division of Infectious Diseases and Global Public Health at the University of... full 4 12 Volume 4, Issue 12

“U=U” — an Undetectable HIV viral load means Untransmittable HIV virus.  In her recent eHIV Newsletter Issue (Vol. 4; No. 11), Dr. Jill Blumenthal from the Division of Infectious Diseases and Global Public Health at the University of California San Diego analyzed the current evidence strongly supporting this concept.  In this Podcast, she discusses “U=U” from the clinical perspective, and models how it can help promote patient safety.

Take our post-test to claim CME credits.

To read a companion newsletter click here


The post “U=U” — Clinical Considerations appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Volume 4, Issue 12

“U=U” — an Undetectable HIV viral load means Untransmittable HIV virus.  In her recent eHIV Newsletter Issue (Vol. 4; No. 11), Dr. Jill Blumenthal from the Division of Infectious Diseases and Global Public Health at the University of California San Diego analyzed the current evidence strongly supporting this concept.  In this Podcast, she discusses “U=U” from the clinical perspective, and models how it can help promote patient safety.

Take our post-test to claim CME credits.

To read a companion newsletter click here


The post “U=U” — Clinical Considerations appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Clinical Aspects of Improving ART Adherence Clinical Aspects of Improving ART Adherence Fri, 14 Jun 2019 19:19:43 GMT 26:53 https://podcast.dkbmed.com/?p=663 false https://shows.acast.com/ehivreview/episodes/5fa6e10573fc5b37cc75ce3a 5fa6e10573fc5b37cc75ce3a 5fa6e0fa73fc5b37cc75ce31 Volume 4, Issue 10 In this Issue, Dr. Joyce Jones from the Johns Hopkins University School of Medicine and Dr. Barbara Taylor from the University of Texas Health Science Center at San Antonio analyze recent publications describing evidence-based ART ad... full 4 10 Volume 4, Issue 10

In this Issue, Dr. Joyce Jones from the Johns Hopkins University School of Medicine and Dr. Barbara Taylor from the University of Texas Health Science Center at San Antonio analyze recent publications describing evidence-based ART adherence interventions and how they can be tailored to specific situations to increase effectiveness.

Take our post-test to claim CME credits.

To read a companion newsletter click here


The post Clinical Aspects of Improving ART Adherence appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Volume 4, Issue 10

In this Issue, Dr. Joyce Jones from the Johns Hopkins University School of Medicine and Dr. Barbara Taylor from the University of Texas Health Science Center at San Antonio analyze recent publications describing evidence-based ART adherence interventions and how they can be tailored to specific situations to increase effectiveness.

Take our post-test to claim CME credits.

To read a companion newsletter click here


The post Clinical Aspects of Improving ART Adherence appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Clinical Perspective: New AEs from Newer ART Clinical Perspective: New AEs from Newer ART Wed, 10 Apr 2019 18:26:23 GMT 23:28 https://podcast.dkbmed.com/?p=651 false https://shows.acast.com/ehivreview/episodes/5fa6e10573fc5b37cc75ce3b 5fa6e10573fc5b37cc75ce3b 5fa6e0fa73fc5b37cc75ce31 Volume 4, Issue 8 While newer antiviral agents like darunavir and the integrase strand transfer inhibitor (INSTI) dolutegravir have shown great efficacy, recent postmarketing surveillance has identified important adverse effects not found in the clinic... full 4 8 Volume 4, Issue 8

While newer antiviral agents like darunavir and the integrase strand transfer inhibitor (INSTI) dolutegravir have shown great efficacy, recent postmarketing surveillance has identified important adverse effects not found in the clinical trial populations.

In this issue, Dr. Cody Chastain from the Division of Infectious Diseases at Vanderbilt University Medical Center discusses how these new findings can impact the clinical use of these new agents.

Take our post-test to claim CME credits.

To read a companion newsletter click here


The post Clinical Perspective: New AEs from Newer ART appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Volume 4, Issue 8

While newer antiviral agents like darunavir and the integrase strand transfer inhibitor (INSTI) dolutegravir have shown great efficacy, recent postmarketing surveillance has identified important adverse effects not found in the clinical trial populations.

In this issue, Dr. Cody Chastain from the Division of Infectious Diseases at Vanderbilt University Medical Center discusses how these new findings can impact the clinical use of these new agents.

Take our post-test to claim CME credits.

To read a companion newsletter click here


The post Clinical Perspective: New AEs from Newer ART appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Clinical Challenges of Engaging PWID and MSM in HIV Care Clinical Challenges of Engaging PWID and MSM in HIV Care Thu, 31 Jan 2019 06:00:30 GMT 22:56 https://podcast.dkbmed.com/?p=631 false https://shows.acast.com/ehivreview/episodes/5fa6e10573fc5b37cc75ce3c 5fa6e10573fc5b37cc75ce3c 5fa6e0fa73fc5b37cc75ce31 Volume 4, Issue 6. Linking high-risk populations like PWIDs (people who inject drugs) and MSM (men who have sex with men) to effective HIV care requires overcoming complex barriers unique to these groups. In this issue, full 4 6 Volume 4, Issue 6.

Linking high-risk populations like PWIDs (people who inject drugs) and MSM (men who have sex with men) to effective HIV care requires overcoming complex barriers unique to these groups.

In this issue, two of the directors from Boston’s Health Care for the Homeless Program, Dr. Jennifer Brody, Director of HIV Services and ANP Marguerite Beiser, Director of HCV Services, discuss the clinical aspects of addressing these challenges.

Take our post-test to claim CME credits.

To read a companion newsletter click here.


The post Clinical Challenges of Engaging PWID and MSM in HIV Care appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Volume 4, Issue 6.

Linking high-risk populations like PWIDs (people who inject drugs) and MSM (men who have sex with men) to effective HIV care requires overcoming complex barriers unique to these groups.

In this issue, two of the directors from Boston’s Health Care for the Homeless Program, Dr. Jennifer Brody, Director of HIV Services and ANP Marguerite Beiser, Director of HCV Services, discuss the clinical aspects of addressing these challenges.

Take our post-test to claim CME credits.

To read a companion newsletter click here.


The post Clinical Challenges of Engaging PWID and MSM in HIV Care appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> In the Clinic: ART and Metabolic Effects In the Clinic: ART and Metabolic Effects Thu, 29 Nov 2018 06:00:29 GMT 23:35 https://podcast.dkbmed.com/?p=596 false https://shows.acast.com/ehivreview/episodes/5fa6e10573fc5b37cc75ce3d 5fa6e10573fc5b37cc75ce3d 5fa6e0fa73fc5b37cc75ce31 Volume 4, Issue 4. The incidence of the metabolic complications common in people with HIV infection — bone disease, weight gain, cardiovascular disease, and liver disease — is increasing as improved antiretroviral therapies create longer lifespans. full 4 4 Volume 4, Issue 4.


The incidence of the metabolic complications common in people with HIV infection — bone disease, weight gain, cardiovascular disease, and liver disease — is increasing as improved antiretroviral therapies create longer lifespans.

In this issue, Dr. Suman Srinivasa and nurse practitioner Kathleen Fitch from Harvard Medical School discuss how to identify and manage these metabolic complications to help improve outcomes and quality of life in patients living with HIV.

Take our post-test to claim CME credits.

To read a companion newsletter click here.

The post In the Clinic: ART and Metabolic Effects appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Volume 4, Issue 4.


The incidence of the metabolic complications common in people with HIV infection — bone disease, weight gain, cardiovascular disease, and liver disease — is increasing as improved antiretroviral therapies create longer lifespans.

In this issue, Dr. Suman Srinivasa and nurse practitioner Kathleen Fitch from Harvard Medical School discuss how to identify and manage these metabolic complications to help improve outcomes and quality of life in patients living with HIV.

Take our post-test to claim CME credits.

To read a companion newsletter click here.

The post In the Clinic: ART and Metabolic Effects appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> New ART Agents: A Clinical Perspective New ART Agents: A Clinical Perspective Thu, 27 Sep 2018 06:00:01 GMT 30:15 https://podcast.dkbmed.com/?p=211 false https://shows.acast.com/ehivreview/episodes/5fa6e10573fc5b37cc75ce3e 5fa6e10573fc5b37cc75ce3e 5fa6e0fa73fc5b37cc75ce31 Volume 4, Issue 2. Recently approved treatment options and new antiviral therapies still under investigation — through case-based discussion, Dr. Ethel Weld from the Division of Clinical Pharmacology and Infectious Diseases at the Johns Hopkins Univers... full 4 2 Volume 4, Issue 2.


To read a companion newsletter click here.

The post New ART Agents: A Clinical Perspective appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Volume 4, Issue 2.


To read a companion newsletter click here.

The post New ART Agents: A Clinical Perspective appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> In The Clinic: Improving Outcomes in At-Risk Populations In The Clinic: Improving Outcomes in At-Risk Populations Mon, 09 Apr 2018 06:00:28 GMT 27:12 https://podcast.dkbmed.com/?p=217 false https://shows.acast.com/ehivreview/episodes/5fa6e10573fc5b37cc75ce3f 5fa6e10573fc5b37cc75ce3f 5fa6e0fa73fc5b37cc75ce31 Volume 3, Issue 8. In this podcast Drs. Allison Agwu evaluates the specific barriers to testing and entering into care among transsexual individuals, migrant and immigrant populations, and adolescents. Take our post-test to claim CME credits. Volume 3, Issue 8.

In this podcast Drs. Allison Agwu evaluates the specific barriers to testing and entering into care among transsexual individuals, migrant and immigrant populations, and adolescents.

Take our post-test to claim CME credits.

To read a companion newsletter click here.

The post In The Clinic: Improving Outcomes in At-Risk Populations appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Volume 3, Issue 8.

In this podcast Drs. Allison Agwu evaluates the specific barriers to testing and entering into care among transsexual individuals, migrant and immigrant populations, and adolescents.

Take our post-test to claim CME credits.

To read a companion newsletter click here.

The post In The Clinic: Improving Outcomes in At-Risk Populations appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> New Advances in ART New Advances in ART Wed, 31 Jan 2018 06:00:45 GMT 31:19 https://podcast.dkbmed.com/?p=254 false https://shows.acast.com/ehivreview/episodes/5fa6e10573fc5b37cc75ce40 5fa6e10573fc5b37cc75ce40 5fa6e0fa73fc5b37cc75ce31 Volume 3, Issue 6. In this podcast about ART, Dr. Rachel Simmons from Boston University School of Medicine discusses recent research that may improve clinicians’ ability to more effectively and more safely manage their patients with HIV infection. Volume 3, Issue 6.

In this podcast about ART, Dr. Rachel Simmons from Boston University School of Medicine discusses recent research that may improve clinicians' ability to more effectively and more safely manage their patients with HIV infection.

Take our post-test to claim CME credits.

To read a companion newsletter click here.

The post New Advances in ART appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Volume 3, Issue 6.

In this podcast about ART, Dr. Rachel Simmons from Boston University School of Medicine discusses recent research that may improve clinicians' ability to more effectively and more safely manage their patients with HIV infection.

Take our post-test to claim CME credits.

To read a companion newsletter click here.

The post New Advances in ART appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Pre-Exposure Prophylaxis: Addressing Provider and Patient Barriers Pre-Exposure Prophylaxis: Addressing Provider and Patient Barriers Sat, 18 Nov 2017 20:27:56 GMT 33:48 https://podcast.dkbmed.com/?p=219 false https://shows.acast.com/ehivreview/episodes/5fa6e10573fc5b37cc75ce41 5fa6e10573fc5b37cc75ce41 5fa6e0fa73fc5b37cc75ce31 Volume 3, Issue 4. In this podcast, Dr. Douglas Krakower discusses pre-exposure prophylaxis and addresses provider and patient barriers to PrEP. Take our post-test to claim CME credits. To read a companion newsletter click here. Volume 3, Issue 4.

In this podcast, Dr. Douglas Krakower discusses pre-exposure prophylaxis and addresses provider and patient barriers to PrEP.

Take our post-test to claim CME credits.

To read a companion newsletter click here.

The post Pre-Exposure Prophylaxis: Addressing Provider and Patient Barriers appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Volume 3, Issue 4.

In this podcast, Dr. Douglas Krakower discusses pre-exposure prophylaxis and addresses provider and patient barriers to PrEP.

Take our post-test to claim CME credits.

To read a companion newsletter click here.

The post Pre-Exposure Prophylaxis: Addressing Provider and Patient Barriers appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> HIV: Management of Concomitant Conditions HIV: Management of Concomitant Conditions Sat, 30 Sep 2017 06:00:35 GMT 27:17 https://podcast.dkbmed.com/?p=221 false https://shows.acast.com/ehivreview/episodes/5fa6e10573fc5b37cc75ce42 5fa6e10573fc5b37cc75ce42 5fa6e0fa73fc5b37cc75ce31 Volume 3, Issue 2. In this podcast Dr. Alysse Wurcel discusses important drug-drug interactions that may impact the treatment of ischemic heart disease in people living with HIV, medication interactions that could influence the treatment of common como... Volume 3, Issue 2.

In this podcast Dr. Alysse Wurcel discusses important drug-drug interactions that may impact the treatment of ischemic heart disease in people living with HIV, medication interactions that could influence the treatment of common comorbid diseases, and potential drug-drug interactions between antiretroviral agents and common over-the-counter medications.

Take our post-test to claim CME credits.

To read a companion newsletter click here.

The post HIV: Management of Concomitant Conditions appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Volume 3, Issue 2.

In this podcast Dr. Alysse Wurcel discusses important drug-drug interactions that may impact the treatment of ischemic heart disease in people living with HIV, medication interactions that could influence the treatment of common comorbid diseases, and potential drug-drug interactions between antiretroviral agents and common over-the-counter medications.

Take our post-test to claim CME credits.

To read a companion newsletter click here.

The post HIV: Management of Concomitant Conditions appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> HIV and Alcohol HIV and Alcohol Thu, 28 May 2015 06:00:20 GMT 28:54 https://podcast.dkbmed.com/?p=223 false https://shows.acast.com/ehivreview/episodes/5fa6e10573fc5b37cc75ce43 5fa6e10573fc5b37cc75ce43 5fa6e0fa73fc5b37cc75ce31 Volume 2, Issue 12. Geetanjali Chander, MD, MPH, Associate Professor of Medicine covers the important topic of HIV and Alcohol in the format of case-study scenarios for the clinical practice. Volume 2, Issue 12.

Geetanjali Chander, MD, MPH, Associate Professor of Medicine covers the important topic of HIV and Alcohol in the format of case-study scenarios for the clinical practice.

The post HIV and Alcohol appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Volume 2, Issue 12.

Geetanjali Chander, MD, MPH, Associate Professor of Medicine covers the important topic of HIV and Alcohol in the format of case-study scenarios for the clinical practice.

The post HIV and Alcohol appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Current Issues in HIV/HCV Coinfection Current Issues in HIV/HCV Coinfection Thu, 26 Mar 2015 06:00:20 GMT 30:31 https://podcast.dkbmed.com/?p=225 false https://shows.acast.com/ehivreview/episodes/5fa6e10573fc5b37cc75ce44 5fa6e10573fc5b37cc75ce44 5fa6e0fa73fc5b37cc75ce31 Volume 2, Issue 10. Shobha Swaminathan, MD, Assistant Professor of Medicine in the Divisions of Infectious Diseases at Rutgers New Jersey Medical School, covers the important topic of Current Issues in HIV/HCV Coinfection. Volume 2, Issue 10.

Shobha Swaminathan, MD, Assistant Professor of Medicine in the Divisions of Infectious Diseases at Rutgers New Jersey Medical School, covers the important topic of Current Issues in HIV/HCV Coinfection.

The post Current Issues in HIV/HCV Coinfection appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Volume 2, Issue 10.

Shobha Swaminathan, MD, Assistant Professor of Medicine in the Divisions of Infectious Diseases at Rutgers New Jersey Medical School, covers the important topic of Current Issues in HIV/HCV Coinfection.

The post Current Issues in HIV/HCV Coinfection appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> HIV-Associated Cardiovascular Disease: An Update HIV-Associated Cardiovascular Disease: An Update Thu, 29 Jan 2015 06:00:51 GMT 25:04 https://podcast.dkbmed.com/?p=227 false https://shows.acast.com/ehivreview/episodes/5fa6e10573fc5b37cc75ce45 5fa6e10573fc5b37cc75ce45 5fa6e0fa73fc5b37cc75ce31 Volume 2, Issue 8. Thomas Metkus, MD, Fellow in cardiovascular medicine, covers the important topic of HIV-Associated Cardiovascular Disease in the format of case-study scenarios for the clinical practice. Volume 2, Issue 8.

Thomas Metkus, MD, Fellow in cardiovascular medicine, covers the important topic of HIV-Associated Cardiovascular Disease in the format of case-study scenarios for the clinical practice.

The post HIV-Associated Cardiovascular Disease: An Update appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Volume 2, Issue 8.

Thomas Metkus, MD, Fellow in cardiovascular medicine, covers the important topic of HIV-Associated Cardiovascular Disease in the format of case-study scenarios for the clinical practice.

The post HIV-Associated Cardiovascular Disease: An Update appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Treating Youth and Young Adults With HIV Infection Treating Youth and Young Adults With HIV Infection Tue, 25 Nov 2014 06:00:27 GMT 33:20 https://podcast.dkbmed.com/?p=229 false https://shows.acast.com/ehivreview/episodes/5fa6e10573fc5b37cc75ce46 5fa6e10573fc5b37cc75ce46 5fa6e0fa73fc5b37cc75ce31 Volume 2, Issue 6. Allison Agwu, Associate Professor of Pediatrics and Infectious Diseases, covers the important topic of Treating Youth and Young Adults with HIV Infection in the format of case-study scenarios for the clinical practice. Volume 2, Issue 6.

Allison Agwu, Associate Professor of Pediatrics and Infectious Diseases, covers the important topic of Treating Youth and Young Adults with HIV Infection in the format of case-study scenarios for the clinical practice.

The post Treating Youth and Young Adults With HIV Infection appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Volume 2, Issue 6.

Allison Agwu, Associate Professor of Pediatrics and Infectious Diseases, covers the important topic of Treating Youth and Young Adults with HIV Infection in the format of case-study scenarios for the clinical practice.

The post Treating Youth and Young Adults With HIV Infection appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> New Recommendations for HAART in HIV New Recommendations for HAART in HIV Thu, 25 Sep 2014 06:00:46 GMT 29:54 https://podcast.dkbmed.com/?p=231 false https://shows.acast.com/ehivreview/episodes/5fa6e10573fc5b37cc75ce47 5fa6e10573fc5b37cc75ce47 5fa6e0fa73fc5b37cc75ce31 Volume 2, Issue 4. Joel Gallant, MD, MPH, Associate Medical Director of Specialty Services at Southwest CARE Center, covers the important topic of new recommendations for HAART in HIV in the format of case-study scenarios for the clinical practice. Volume 2, Issue 4.

Joel Gallant, MD, MPH, Associate Medical Director of Specialty Services at Southwest CARE Center, covers the important topic of new recommendations for HAART in HIV in the format of case-study scenarios for the clinical practice.

The post New Recommendations for HAART in HIV appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Volume 2, Issue 4.

Joel Gallant, MD, MPH, Associate Medical Director of Specialty Services at Southwest CARE Center, covers the important topic of new recommendations for HAART in HIV in the format of case-study scenarios for the clinical practice.

The post New Recommendations for HAART in HIV appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Women and HIV Women and HIV Thu, 31 Jul 2014 06:00:13 GMT 36:48 https://podcast.dkbmed.com/?p=233 false https://shows.acast.com/ehivreview/episodes/5fa6e10573fc5b37cc75ce48 5fa6e10573fc5b37cc75ce48 5fa6e0fa73fc5b37cc75ce31 Volume 2, Issue 2. Jean Anderson, MD, Professor of Gynecology and Obstetrics, and Medicine, and Jenell Coleman, MD, Assistant Professor of Gynecology and Obstetrics, and Medicine at the Johns Hopkins University School of Medicine discuss the important ... Volume 2, Issue 2.

Jean Anderson, MD, Professor of Gynecology and Obstetrics, and Medicine, and Jenell Coleman, MD, Assistant Professor of Gynecology and Obstetrics, and Medicine at the Johns Hopkins University School of Medicine discuss the important topic of Women and HIV in the format of case-study scenarios for the clinical practice.

The post Women and HIV appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Volume 2, Issue 2.

Jean Anderson, MD, Professor of Gynecology and Obstetrics, and Medicine, and Jenell Coleman, MD, Assistant Professor of Gynecology and Obstetrics, and Medicine at the Johns Hopkins University School of Medicine discuss the important topic of Women and HIV in the format of case-study scenarios for the clinical practice.

The post Women and HIV appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Emerging Promises and Challenges with the Use of Antiretroviral Therapy for Prevention of HIV Transmission Emerging Promises and Challenges with the Use of Antiretroviral Therapy for Prevention of HIV Transmission Tue, 21 May 2013 06:00:42 GMT 30:18 https://podcast.dkbmed.com/?p=235 false https://shows.acast.com/ehivreview/episodes/5fa6e10573fc5b37cc75ce49 5fa6e10573fc5b37cc75ce49 5fa6e0fa73fc5b37cc75ce31 Volume 1, Issue 12. Dr. Kenneth H. Mayer from Harvard discusses the important issues related to Pre-Exposure Prophylaxis (PrEP) in HIV-uninfected individuals at high-risk and reviews the results of several key studies that evaluated the use of PrEP. Volume 1, Issue 12.

Dr. Kenneth H. Mayer from Harvard discusses the important issues related to Pre-Exposure Prophylaxis (PrEP) in HIV-uninfected individuals at high-risk and reviews the results of several key studies that evaluated the use of PrEP.

The post Emerging Promises and Challenges with the Use of Antiretroviral Therapy for Prevention of HIV Transmission appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Volume 1, Issue 12.

Dr. Kenneth H. Mayer from Harvard discusses the important issues related to Pre-Exposure Prophylaxis (PrEP) in HIV-uninfected individuals at high-risk and reviews the results of several key studies that evaluated the use of PrEP.

The post Emerging Promises and Challenges with the Use of Antiretroviral Therapy for Prevention of HIV Transmission appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Human Immunodeficiency Virus and Hepatitis C Virus Coinfection Human Immunodeficiency Virus and Hepatitis C Virus Coinfection Tue, 19 Mar 2013 06:00:18 GMT 35:38 https://podcast.dkbmed.com/?p=237 false https://shows.acast.com/ehivreview/episodes/5fa6e10573fc5b37cc75ce4a 5fa6e10573fc5b37cc75ce4a 5fa6e0fa73fc5b37cc75ce31 Volume 1, Issue 10. Our guest author is Mark Sulkowski, MD, Professor of Medicine, Medical Director of the Viral Hepatitis Center, Division of Infectious Diseases and Gastroenterology/Hepatology at the Johns Hopkins University School of Medicine in Bal... Volume 1, Issue 10.

Our guest author is Mark Sulkowski, MD, Professor of Medicine, Medical Director of the Viral Hepatitis Center, Division of Infectious Diseases and Gastroenterology/Hepatology at the Johns Hopkins University School of Medicine in Baltimore, Maryland.

The post Human Immunodeficiency Virus and Hepatitis C Virus Coinfection appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Volume 1, Issue 10.

Our guest author is Mark Sulkowski, MD, Professor of Medicine, Medical Director of the Viral Hepatitis Center, Division of Infectious Diseases and Gastroenterology/Hepatology at the Johns Hopkins University School of Medicine in Baltimore, Maryland.

The post Human Immunodeficiency Virus and Hepatitis C Virus Coinfection appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> HIV-Associated Neurocognitive Disorder (HAND) HIV-Associated Neurocognitive Disorder (HAND) Tue, 15 Jan 2013 06:00:57 GMT 33:43 https://podcast.dkbmed.com/?p=239 false https://shows.acast.com/ehivreview/episodes/5fa6e10573fc5b37cc75ce4b 5fa6e10573fc5b37cc75ce4b 5fa6e0fa73fc5b37cc75ce31 Volume 1, Issue 8. Drs Justin McArthur and Bryan Smith present three patient cases on the topic of HIV-Associated Neurocognitive Disorder (HAND) Volume 1, Issue 8.

Drs Justin McArthur and Bryan Smith present three patient cases on the topic of HIV-Associated Neurocognitive Disorder (HAND)

The post HIV-Associated Neurocognitive Disorder (HAND) appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Volume 1, Issue 8.

Drs Justin McArthur and Bryan Smith present three patient cases on the topic of HIV-Associated Neurocognitive Disorder (HAND)

The post HIV-Associated Neurocognitive Disorder (HAND) appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Bone Health, Vitamin D, and HIV Bone Health, Vitamin D, and HIV Tue, 20 Nov 2012 06:00:40 GMT 33:30 https://podcast.dkbmed.com/?p=241 false https://shows.acast.com/ehivreview/episodes/5fa6e10573fc5b37cc75ce4c 5fa6e10573fc5b37cc75ce4c 5fa6e0fa73fc5b37cc75ce31 Volume 1, Issue 6. Dr. Todd Brown, Associate Professor of Medicine in the Division of Endocrinology and Metabolism at The Johns Hopkins University School of Medicine will explain the management of an HIV-infected person with osteoporosis, Volume 1, Issue 6.

Dr. Todd Brown, Associate Professor of Medicine in the Division of Endocrinology and Metabolism at The Johns Hopkins University School of Medicine will explain the management of an HIV-infected person with osteoporosis, and discuss the controversies surrounding vitamin D screening and treatment.

The post Bone Health, Vitamin D, and HIV appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Volume 1, Issue 6.

Dr. Todd Brown, Associate Professor of Medicine in the Division of Endocrinology and Metabolism at The Johns Hopkins University School of Medicine will explain the management of an HIV-infected person with osteoporosis, and discuss the controversies surrounding vitamin D screening and treatment.

The post Bone Health, Vitamin D, and HIV appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Linkage and Retention in HIV Medical Care Linkage and Retention in HIV Medical Care Tue, 18 Sep 2012 06:00:49 GMT 37:08 https://podcast.dkbmed.com/?p=243 false https://shows.acast.com/ehivreview/episodes/5fa6e10573fc5b37cc75ce4d 5fa6e10573fc5b37cc75ce4d 5fa6e0fa73fc5b37cc75ce31 Volume 1, Issue 4. Our Guest Author is Michael Mugavero, MD, Associate Professor of Medicine and Director of the Center for AIDS Research Clinical Core at the University of Alabama at Birmingham. Volume 1, Issue 4.

Our Guest Author is Michael Mugavero, MD, Associate Professor of Medicine and Director of the Center for AIDS Research Clinical Core at the University of Alabama at Birmingham.

The post Linkage and Retention in HIV Medical Care appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Volume 1, Issue 4.

Our Guest Author is Michael Mugavero, MD, Associate Professor of Medicine and Director of the Center for AIDS Research Clinical Core at the University of Alabama at Birmingham.

The post Linkage and Retention in HIV Medical Care appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Screening and Management of Older Patients with HIV Screening and Management of Older Patients with HIV Tue, 17 Jul 2012 06:00:32 GMT 32:09 https://podcast.dkbmed.com/?p=245 false https://shows.acast.com/ehivreview/episodes/5fa6e10573fc5b37cc75ce4e 5fa6e10573fc5b37cc75ce4e 5fa6e0fa73fc5b37cc75ce31 Volume 1, Issue 2. Dr. Kelly Gebo, Associate Professor of Medicine and Epidemiology at the Johns Hopkins Unviersity School of Medicine will discuss the screening of older patients for HIV risk factors. She will also explain the issues of polypharmacy i... Volume 1, Issue 2.

Dr. Kelly Gebo, Associate Professor of Medicine and Epidemiology at the Johns Hopkins Unviersity School of Medicine will discuss the screening of older patients for HIV risk factors. She will also explain the issues of polypharmacy in older HIV infected patients.

The post Screening and Management of Older Patients with HIV appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]> Volume 1, Issue 2.

Dr. Kelly Gebo, Associate Professor of Medicine and Epidemiology at the Johns Hopkins Unviersity School of Medicine will discuss the screening of older patients for HIV risk factors. She will also explain the issues of polypharmacy in older HIV infected patients.

The post Screening and Management of Older Patients with HIV appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

]]>